| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |